ALSO NOTED: Smith & Nephew move to China; Orion defends patent;

> Smith & Nephew says it will close a Florida plant and move its operations there to China. Report

> Finnish drug maker Orion says it may turn to the courts to defend its patents on entacapone, the active ingredient in its Parkinson's drug Comtan. Marketed in the U.S. by Novartis, the drug faces possible competition from an unnamed generics manufacturer, which has filed an Abbreviated New Drug Application to produce its own version. Report

> Premiums for Medicare Part D are only increasing by 14 percent for 2008, the Centers for Medicare and Medicare Services announced. The price is nearly 40 percent less than original projections made when the law was passed in 2003. Seniors will pay $25 next year, compared with $22 this year. Report

And Finally... Researchers have found a new target that may be the key to raising levels of "good" cholesterol--a hot topic in drug discovery circles. FierceBioResearcher

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

North Korean hackers were accused of posing as corporate recruiters in a scheme to breach AstraZeneca's computer systems and steal COVID-19 research.

The FDA has delayed its review of Revance's frown-line injection candidate after it failed to inspect a key manufacturing facility on time.

McKinsey & Company helped guide Purdue's strategy for years and pitched the idea of rebates to distributors for overdoses, according to the NYT.